Monika Alcobev SME
smeListed
GMP
₹0
smeListed
Monika Alcobev SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹0
Investment Timeline
✓
IPO Open
16 Jul 2025
✓
IPO Close
18 Jul 2025
✓
Allotment
21 Jul 2025
✓
Listing
23 Jul 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
AVOID
35.5/100
🎯 Application Strategy
Action: ⛔ AVOID - Better opportunities available elsewhere
Lots: NOT RECOMMENDED
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
⚠️ Moderate subscription - average investor interest
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
❌ Risk of listing at discount or minimal gains
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹271.00-286.00
📦Lot Size
400 shares
💰Issue Size
₹153.68 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Monika Alcobev SME?
As of today, the Grey Market Premium (GMP) for Monika Alcobev SME is ₹0, which is approximately null of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Monika Alcobev SME?
Our AI algorithm currently rates this IPO as "AVOID" with a score of 35.5/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Monika Alcobev SME be announced?
The allotment status for Monika Alcobev SME is expected to be finalized on 21 Jul 2025. Investors can check their status on the registrar's website.
What is the listing date for Monika Alcobev SME?
Shares of Monika Alcobev SME are proposed to be listed on stock exchanges on 23 Jul 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.